Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neotherapuetics possibly has a breakthrough drug - NEOT -- Ignore unavailable to you. Want to Upgrade?

To: Marty who wrote (28)	8/27/1999 2:47:00 PM
From: Marty	Read Replies (1) \| Respond to of 204

I just can't make any sense out of NEOT anymore. Sometimes I think that they just can't understand, despite the last episode with the secondary, that the financial community will punish them severely for not keeping them fully informed about what is going on. As a consequence, they will never be able to get the funds to finish their tests to get the drug to market. Besides that, the marketplace will put the worst connotation on it - that things aren't going that well. Sooner or later, the market will interpret "no comment" as bad news. (Ask G. Bush, Jr.) There are lots of biotech companies who have been scrambling around for years trying to get funding for their projects. Sometimes I believe the alternate interpretation that the real reason is that they truly believe they really have the drug and they don't care what anyone thinks or says. The drug is all that counts. They are not going to do anything to risk even a dirty look from the SEC or the FDA. If it comes to a contest between them on the one hand or the stockholders and potential investors on the other hand, the FDA & the SEC win, going away. Why they can't ask simply ask them if some draft release would be considered "promotional" is beyond me. The basic problem is that on a scale of 1 to 100 with FDA/SEC on the left and shareholders on the right, NEOT is at a 6. The danger zone doesn't start until you get to, say, 80. So they punish themselves and us, needlessly. If they deign not to comment on a 38% loss in the value of the stock, and tell us what happened and why and how it has been fixed, and what the status is now, in plain English, I interpret that as "more of the same" and, personally, I would no longer care what happens. I am tired of lurching from rumor to rumor and wondering what is going on.